Treatment and outcome of ulcerative colitis during the first 10 years after diagnosis in a prospectively followed population-based cohort
{{output}}
Background and aims: There is a shortage of studies evaluating the effect of prevalent use of immunomodulators (IMMs) and biologicals on the clinical course of ulcerative colitis (UC) during 10 years. The aim of the present study... ...
